Robert Roche Insider Profile
4 Followers
Robert Roche, former Director at Antares Pharma, holds 167.82K shares in Antares Pharma (Ticker: ATRS), holds ― shares in Egalet Corp (Ticker: EGLTQ), holds 0.00 shares in Aratana (Ticker: PETX).
Robert Roche's Trading History
| ATRSAntares Pharma | Jun 14, 2021 | ― | Uninformative Buy | 112.50K | $938.10K | |
| PETXAratana | Jul 18, 2019 | ― | Uninformative Sell | ― | $0.00 | |
| ~PATHNupathe Inc | Feb 25, 2014 | ― | Uninformative Sell | 159.80K | ― | |
| EGLTQEgalet Corp | ― | ― | ― | ― |
You May Also Like
Robert Roche insider profile FAQ
What is the percentage of profitable transactions made by Robert Roche?
The percentage of profitable transactions made by Robert Roche is 25%.
What is the average return per transaction made by Robert Roche?
The average return per transaction made by Robert Roche is 45.60%.
What stocks does Robert Roche hold?
Robert Roche holds: ATRS, EGLTQ, PETX, ~PATH stocks.
What was Robert Roche’s latest transaction?
Robert Roche’s latest transaction was an Uninformative Buy of $112.50K.
What was Robert Roche's most profitable transaction?
Robert Roche’s most profitable transaction was an Informative Buy of ATRS stock on March 22, 2016. The return on the trade was 263.60%.
What is Robert Roche's role in Antares Pharma?
Robert Roche's role in Antares Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
